Diagnostics & Tools March 2021

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Roche has agreed to acquire GenMark Diagnostics for $1.9bb
• Agilent Technologies has agreed to acquire Resolution Bioscience for approximately $700mm
• Bio-techne has agreed to acquire Asuragen for $320mm